Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
31.38
-1.45 (-4.42%)
At close: Jul 10, 2026, 4:00 PM EDT
31.38
0.00 (0.00%)
After-hours: Jul 10, 2026, 5:23 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.95 billion as of July 10, 2026. Its market cap has increased by 203.11% in one year.
Market Cap
1.95B
Enterprise Value
1.55B
1-Year Change
203.11%
Ranking
Category
Stock Price
$31.38
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.95B, an increase of 142.95%. That is a compound annual growth rate of 13.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.95B | 7.81% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palvella Therapeutics | 2.09B |
| Sarepta Therapeutics | 2.09B |
| Aurinia Pharmaceuticals | 2.09B |
| Generate Biomedicines | 2.08B |
| Taysha Gene Therapies | 2.08B |
| Monte Rosa Therapeutics | 2.06B |
| Syndax Pharmaceuticals | 2.06B |
| Recursion Pharmaceuticals | 2.04B |